Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
20 Patents
#66 in South San Francisco, CA
#3,933 in California
#16,382 in US
#31,233 in the World
Oric Pharmaceuticals, Inc.
Forward Citations = 46
33 inventors:
South San Francisco, CA, United States of America
Oric Pharmaceuticals, Inc.
% Expired Patents = 10.0
CIPO Patents = 2
EPO Patents = 3
Trademarks = 2
Forward Citations = 46
Loading Chart...
Loading Chart...
33 inventors (with patents filed for the assignee):
Xiaohui Du (20 out of 49 patents)
Daqing Sun (18 out of 40 patents)
John Eksterowicz (18 out of 24 patents)
4. Valeria R Fantin (17 out of 19 patents)
5. Yosup Rew (15 out of 29 patents)
6. Jared Moore (14 out of 15 patents)
7. Liusheng Zhu (14 out of 34 patents)
8. Qiuping Ye (12 out of 12 patents)
9. Kejia Wu (11 out of 11 patents)
10. Hiroyuki Kawai (11 out of 11 patents)
11. Tatiana Zavorotinskaya (10 out of 11 patents)
12. Johnny Pham (9 out of 9 patents)
13. Brian Richard Blank (9 out of 11 patents)
14. Chien-Hung Yeh (7 out of 7 patents)
15. Xuelei Yan (6 out of 31 patents)
20 patents:
Company Overview
Oric Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for cancer treatment. The company specializes in targeting the mechanisms of drug resistance in cancer cells, aiming to improve patient outcomes through precision medicine. Oric's research leverages advanced technologies to identify and develop novel compounds that can effectively address unmet medical needs in oncology, positioning the company at the forefront of cancer therapeutics.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oric Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/oric-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]